The use of IHC of the cell lineage-specific TFs SF1, TPIT, and PIT1 enhances the diagnostic accuracy of clinically NFPA subtypes, enabling us to adjust clinical and radiological follow-up, and potentially treatment. Here, TBX19 is linked to non-functioning pituitary adenoma.